| Literature DB >> 30548198 |
Mengchao Yu1, Zhijian Liu2, Yuan Liu1, Xinyan Zhou1, Feng Sun2, Yanqing Liu1, Liuyi Li1, Shiyu Hua1, Yi Zhao1, Haidong Gao1, Zhouting Zhu2, Muhan Na1, Qipeng Zhang1, Rong Yang3, Jianguo Zhang4, Yongzhong Yao2, Xi Chen1.
Abstract
The protein tyrosine phosphatase PTP1B, which is encoded by PTPN1, is a ubiquitously expressed nonreceptor protein tyrosine phosphatase. PTP1B has long been known to negatively regulate insulin and leptin receptor signalling. Recently, it was reported to be aberrantly expressed in cancer cells and to function as an important oncogene. In this study, we found that PTP1B protein levels are dramatically increased in breast cancer (BC) tissues and that PTP1B promotes the proliferation, and suppresses the apoptosis, of both HER2-positive and triple-negative BC cell lines. Bioinformatics analysis identified that the miRNA, miR-193a-3p, might potentially target PTP1B. We demonstrate that miR-193a-3p regulates PTP1B in BC cells and that it regulates the proliferation and apoptosis of BC cells by targeting PTP1B, both in vitro and in vivo. In conclusion, this study confirms that PTP1B acts as an oncogene in BC and demonstrates that miR-193a-3p can serve as a tumour suppressor gene in BC by targeting PTP1B.Entities:
Keywords: PTP1B; apoptosis; breast cancer; miR-193a-3p; proliferation
Year: 2018 PMID: 30548198 DOI: 10.1111/febs.14724
Source DB: PubMed Journal: FEBS J ISSN: 1742-464X Impact factor: 5.542